Predicting growth in response to growth hormone treatment - the kigs approach

Growth Hormone Therapy in Pediatrics-20 Years of KIGS

Volumn , Issue , 2007, Pages 422-431

  Ranke, Michael B ^a   Lindberg, Anders ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65549090132     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000101933     Document Type: Chapter

References (38)

1. Preece MA, Tanner JM, Whitehouse RM, Cameron N: Dose dependence of growth response to human growth hormone in growth hormone deficiency. J Clin Endocrinol Metab 1976; 42: 477-483.
2. Frasier SD, Costin G, Lippe BM, Aceto T Jr, Bunger PF: A doseresponse curve for human growth hormone. J Clin Endocrinol Metab 1981; 53: 1213-1217.
3. Albertsson-Wikland K: The effect of human growth hormone injection frequency on linear growth rate. Acta Paediatr Scand 1987; 337: 110-116.
4. Wit JM, van't Hof MA, van den Brande JL: The effect of human growth hormone therapy on skinfold thickness in growth hormone-deficient children. Eur J Pediatr 1988; 147: 588-592.
5. Sherman B, Frane J, Johanson AJ, Kaplan SL: Predictors of response in treatment with methionyl human growth hormone; in Underwood LE (ed): Human Growth Hormone. Progress and Challenges. New York, Marcel Dekker, 1988, pp 131-142.
6. Ranke MB, Guilbaud O: Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with growth hormone. Analysis of the Kabi Pharmacia International Growth Study. Acta Paediatr Scand Suppl 1991; 379: 109-115.
7. Ranke MB, Guilbaud O, Lindberg A, Cole T: Prediction of the growth response in children with various growth disorders treated with growth hormone: analysis of data from the Kabi Pharmacia International Growth Study. Acta Paediatr Scand Suppl 1993; 391: 82-88.
8. Blethen SL, Compton P, Lippe BM, Rosenfeld RG, August GP, Johanson A: Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency. J Clin Endocrinol Metab 1993; 76: 574-579.
9. Ranke MB, Lindberg A, Guilbaud O: Prediction of growth response to treatment with growth hormone; in Ranke MB, Gunnarsson R (eds): Progress in Growth Hormone Therapy - 5 Years of KIGS. Mannheim, J&J Verlag, 1994, pp 97-111.
10. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield, Albertsson-Wikland K, Price DA: Development of the KIGS model for predicting growth response to growth hormone replacement therapy in children with idiopathic growth hormone deficiency from start of treatment until final height; in Ranke MB, Wilton P (eds): Growth Hormone Therapy in KIGS - 10 Years' Experience. Heidelberg, Johann Ambrosius Barth, 1997, pp 371-384.
11. Albertsson-Wikland K, Kriström B, Rosberg S, Svensson B, Nierop AFM: Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities. Pediatr Res 2000; 48: 475-484.
12. Cook RD, Weisberg S: Residuals and Influence in Regression. New York, Chapman and Hall, 1982.
13. Weisberg S: Applied Linear Regression, ed 2. Chichester, Wiley and Sons, 1985.
14. Harrell FEJ, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-387.
15. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield WS, Albertsson-Wikland K, Price DA: Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. J Clin Endocrinol Metab 1999; 84: 1174-1183.
16. Ranke MB, Lindberg A, Cowell CT, Wikland KA, Reiter EO, Wilton P, Price DA, KIGS International Board: Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS. J Clin Endocrinol Metab 2003; 88: 125-131.
17. Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO: Increased response, but lower responsiveness to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH deficiency: analysis of data from KIGS. J Clin Endocrinol Metab 2005; 90: 1966-1971.
18. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA, KIGS International Board: Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. J Clin Endocrinol Metab 2000; 85: 4212-4218.
19. Ranke MB, Lindberg A, Martin DD, Bakker B, Wilton P, Albertsson-Wikland K, Cowell CT, Price DA, Reiter EO: The mathematical model for total pubertal growth in idiopathic growth hormone deficiency suggests a moderate role of GH dose. J Clin Endocrinol Metab 2003; 88: 4748-4753.
20. Ranke MB, Guilbaud O: Growth hormone levels in response to stimulation tests and responsiveness to growth hormone in children with growth hormone deficiency and idiopathic short stature. Kabi Pharmacia International Growth Study, Report 8, Biannual Report 1992; 1: 34-41.
21. Spagnioli A, Spadoni GL, Boscherini B: Prediction of the outcome of growth hormone therapy in children with idiopathic short stature. A multivariate discriminant analysis. J Pediatr 1995; 126: 905-909.
22. Südfeld H, Kiese K, Heinecke A, Brämswig JH: Prediction of growth response in prepubertal children treated with growth hormone for idiopathic growth hormone deficiency. Acta Paediatr 2000; 89: 34-37.
23. Schönau E, Westermann F, Rauch F, Stabrey A, Wassmer G, Keller E, Brämswig J, Blum WF: A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency. Eur J Endocrinol 2001; 144: 13-20.
24. Wallström A, Trulsson L: The Kabi International Growth Study: rationale, organisation and development; in Ranke MB, Gunnarsson R (eds): Progress in Growth Hormone Therapy - 5 Years of KIGS. Mannheim, J&J Verlag, 1994, pp 1-9.
25. Ranke MB: The Kabi Pharmacia International Growth Study: aetiology classification list with comments. Acta Paediatr Scand 1991; 379: 87-92.
26. Blethen SA, Baptista J, Kuntze J, Foley T, LaFranchi S, Johanson A, on behalf of the Genentech Study Group: Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. J Clin Endocrinol Metab 1997; 82:418-420.
27. Dowie J: What decision analysis can offer the clinical decision maker. Horm Res 1999; 51(suppl):73-82.
28. Vasahlo J, Zidek T, Lebl J, Riedl S, Frisch H: Validation of a mathematical model predicting the response to growth hormone treatment in prepubertal children with idiopathic growth hormone deficiency. Horm Res 2004; 61: 143-147.
29. De Ridder MAJ, Stijnen T, Hokken-Koelega AC: Validation and calibration of the Kabi Pharmacia International Growth Study prediction model for children with idiopathic growth hormone deficiency. J Clin Endocrinol Metab 2003; 88: 1223-1227.
30. De Ridder MAJ, Stijnen T, Drop SLS, Blum WF, Hokken-Koelega ACS: Validation of a calibrated prediction model for response to growth hormone treatment in an independent cohort. Horm Res 2006; 66: 13-16.
31. Lee KW, Cohen P: Individualized growth hormone therapy in children: advances beyond weight-based dosing. J Pediatr Endocrinol Metab 2003; 16: 625-630.
32. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P: A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 2004; 36: 720-724.
33. Binder G, Baur R, Schweizer R, Ranke MB: The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-forgestational-age children. J Clin Endocrinol Metab 2006; 91: 659-664.
34. Pilotta A, Mella P, Filisetti M, Felappi B, Prandi E, Parrinello G, Notarangelo LD, Buzi F: Common polymorphisms of the growth hormone (GH) receptor do not correlate with the growth response to exogenous recombinant human GH in GH-deficient children. J Clin Endocrinol Metab 2006; 91: 1178-1180.
35. Jorge AA, Marchisotti FG, Montenegro LR, Carvalho LR, Mendonca BB, Arnhold JJ: Growth hormone (GH) pharmacogenomics: influence of GH receptor exon 3 retention or deletion on first year growth response and final height in patients with severe GH eficiency. J Clin Endocrinol Metab 2006; 91: 1076-1080.
36. Kristström B, Jansson C, Rosberg S, Albertsson-Wikland K: Growth response to growth hormone (GH) treatment relates to insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities: Swedish Study Group for Growth Hormone Treatment. J Clin Endocrinol Metab 1997; 82: 2889-2898.
37. Rauch F, Georg M, Stabrey A, Neu C, Blum WF, Remer T, Manz, Schönau E: Collagen markers deoxypyridinoline and hydroxylysine glucoside: pediatric reference data and use for growth prediction in growth hormone-deficient children. Clin Chem 2002; 48: 315-322.
38. Tobiume H, Kanzaki S, Hida S, Ono T, Moriwake, T, Yameuchi S, Tanka H, Seino Y: Serum bone alkaline phosphatase isoenzyme levels in normal children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. J Clin Endocrinol Metab 1997; 82: 2056-2061.